Enzyme, powered by the MLN token, is a digital asset management platform that strives to streamline the management of digital assets. It provides a unified, user-friendly on-chain system that allows access to digital assets and DeFi from a single application. Enzyme aims to eliminate operational risks associated with managing crypto and DeFi assets without purpose-built smart-contract permissions and controls. It provides a robust suite of programmable risk management and governance tools to protect assets. Enzyme also maintains sophisticated on-chain data pipelines, ensuring data is auditable and trustworthy, promoting a future based on transparency and auditability.

Enzyme operates through a system of vaults, each representing a unique portfolio with its own strategy, asset allocation, and investment goals. Users can create multiple vaults and customize each one according to their preferences. Enzyme provides tools for managing and monitoring these portfolios, including performance metrics and detailed reporting. This makes it easy for users to track the performance of their assets and make informed decisions about how to manage their portfolios over time. Enzyme also provides real-time reporting and performance dashboards with key performance and risk metrics, and reports that provide easily readable and provable data on all transactions at any point in history.

Enzyme has a wide range of potential use cases. For instance, it can be used for treasury management, allowing organizations to manage their treasury simply, securely, and transparently. It can also be used to set up an on-chain DeFi fund, with Enzyme taking care of all fund operations and administration using smart-contract automation. Additionally, users can build their own indexes in minutes and have them rebalance automatically on-chain or off-chain. Enzyme also allows anyone to build, scale, and monetize investment strategies using the protocol's non-custodial Vaults. These strategies can span the spectrum from traditional discretionary allocators to DeFi-native combinations of any of the primitives with which Enzyme integrates.

Enzyme, formerly known as the Melon Protocol, was initially developed by the private company Melonport. After the dissolution of Melonport, the protocol was transferred to the Enzyme Council. The protocol has been on the mainnet since February 2019 and was the first DeFi protocol to decentralize its governance. Enzyme v2, a completely re-architected protocol with modularity and extensibility at the core of its design, was launched to the mainnet in January 2021. The Enzyme token, MLN, is used to access the MLN network and incentivize developers to build on Enzyme.

我們實時將 Enzyme 更新為 USD 貨幣。在 Coinbase 上獲取 Enzyme 的實時價格。

Enzyme 目前的市值為 US$399.588万。高市值意味著資產受到市場的高度重視。

Enzyme 的歷史最高紀錄是 US$270.05。這是自從 Enzyme 推出以來的最高價格。

在過去 24 小時中，Enzyme 的交易量為 US$110.174万。

與 Enzyme 市值相似的資產包括 IMPT, Coca-Cola Tokenized Stock (Ondo), Counterparty 和許多其他資產。若要查看完整清單，請參閱我們的可比市值資產。

Enzyme 目前的循環供應量為 328万。

Enzyme 在 Coinbase 的可交易資產中排名 232。受歡迎程度目前是根據相對市值。

目前，63% 的 Coinbase 使用者正在購買 Enzyme。換句話說，63% 的 Coinbase 客戶在過去 24 個小時以內透過交易增加了他們在 Enzyme 中的淨頭寸。